Filter
5862
Filtered Results: 5862
Text search:
epidemic
Featured
Recommendations
512
New Publications
1521
Language
Document type
No document type
3266
Studies & Reports
927
Guidelines
813
Strategic & Response Plan
239
Manuals
230
Fact sheets
184
Situation Updates
71
Training Material
58
Infographics
37
Resource Platforms
22
Online Courses
6
Videos
4
Brochures
3
Dashboards/Maps
1
App
1
Countries / Regions
Global
246
Sierra Leone
178
India
162
Liberia
161
Latin America and the Carribbean
145
Kenya
124
Africa
111
South Africa
105
Western and Central Europe
104
Ethiopia
103
Brazil
103
Nigeria
97
Uganda
93
Zambia
85
Indonesia
85
Nepal
81
Congo, Democratic Republic of
80
Guinea
79
Tanzania
75
Mozambique
74
Rwanda
72
Russia
64
Venezuela
61
Ghana
59
Malawi
59
Ukraine
55
Myanmar / Burma
55
Bangladesh
51
West and Central Africa
51
Namibia
47
Eastern Europe
45
Zimbabwe
44
Asia
44
Peru
43
Lesotho
43
Paraguay
43
East and Southern Africa
41
Middle East and North Africa
38
Colombia
37
Senegal
36
Haiti
36
South–East Asia Region
36
Syria
35
South Sudan
33
Philippines
30
Germany
30
Yemen
30
Angola
28
Cambodia
27
Botswana
26
Argentina
24
Burkina Faso
23
Bolivia
23
Cameroon
21
El Salvador
21
Eastern Europe and Central Asia
21
Madagascar
19
Chile
19
Guinea-Bissau
18
Mali
17
Ecuador
17
Côte d’Ivoire / Ivory Coast
16
Pakistan
15
Sudan
14
Eswatini/ Swaziland
14
Spain
14
Somalia
13
Western Pacific Region
13
Thailand
12
Vietnam
12
Tajikistan
11
China
10
Benin
10
Central African Republic
10
Albania
10
Afghanistan
9
Italy
9
Moldova
9
Georgia
9
Portugal
9
Togo
8
Laos
8
Chad
7
Niger
6
Iraq
6
Jordan
6
Burundi
6
Honduras
6
Southern Africa
6
Iran
6
North America
6
Turkey
5
USA
4
Saudi Arabia
4
Lebanon
4
Egypt
4
Gambia
4
Dominican Republic
4
North Macedonia
4
Mexico
4
Armenia
4
Japan
4
Papua New Guinea
3
Serbia
3
Guatemala
3
Sri Lanka
3
Timor Leste/ East Timor
3
Estonia
3
Kyrgyzstan
3
Kazakhstan
3
Jamaica
3
France
3
Tunisia
3
United Kingdom
3
Morocco
2
Ireland
2
Switzerland
2
Poland
2
Djibouti
2
Turkmenistan
2
Mauritius
2
Malaysia
1
Mauritania
1
Singapore
1
Austria
1
Hungary
1
Croatia
1
Cuba
1
Greece
1
Libya
1
Nicaragua
1
Other region
1
Fiji
1
Bhutan
1
Palestine
1
Canada
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Uzbekistan
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
Morocco
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2271
Clinical Guidelines
389
Public Health
295
Key Resources
218
Women & Child Health
154
Capacity Building
55
Pharmacy & Technologies
44
Annual Report MEDBOX
3
Toolboxes
COVID-19
901
HIV
751
TB
425
Rapid Response
383
Ebola
359
Mental Health
177
Planetary Health
143
NTDs
109
NCDs
107
Zika
106
Conflict
87
Global Health Education
87
Cholera
86
AMR
83
Natural Hazards
76
Caregiver
75
Refugee
64
Health Financing Toolbox
62
Polio
47
Pharmacy
39
Disability
37
Specific Hazards
19
Social Ethics
6
Typhoon
4
South Sudan
1
This document presents the World Health Organization Operational framework for building climate resilient and low carbon health systems*. ***The framework's goal is to increase the climate resilience of health systems to protect and improve the health of communities in an unstable and changing clima...
South Sudan continues to struggle with a severe health crisis affecting 8.9 million people, primarily in flood- and conflict-affected regions with population movements (displacement and returns), and disease outbreaks. The nation's health system, heavily reliant on international aid, faces staffing ...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
The Disaster Recovery Framework (DRF) Guide for the Health Sector provides guidance on how to implement a comprehensive, integrated, and structured approach to disaster recovery. Its overarching goal is to minimize the impact of the disaster on communities and help countries to recover quickly and e...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention and treatment programs. For the first time since the Global Fund’s founding, ...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an ...ological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase i...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
